DCCT: Medical and economical message, five years later

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue SUPPL. 2, 1999, Pages

  Kabadi, Udaya M ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

DCCT; Implementation; Medical and economic impact

Indexed keywords

EID: 0006114150     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212146     Document Type: Article

References (12)

1. American Diabetes Association: Position statement: Standards of medical care for patients with diabetes mellitus. Diabetes Care 22(suppl): 532-541, 1999.
2. Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik, L: The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. Arch Opthalmol 106:1242-6, 1998.
3. Campbell LK, Campbell RK: Cost drivers in diabetes care: the problems they present and potential solutions. (Review). Clinical Therapeutics. 19(3): 540-58 1997.
4. Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien, D: Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 261:115-60, 1989.
5. Crofford OB: Diabetes control and complications (Review). Annual Review of Medicine 46: 267-79, 1995.
6. Dagogo-Jack S: DCCT results and diabetes care in developing countries. Diabetes Care 18(3): 416-17, 1995.
7. DCCT Research Group: Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 18(11): 1415-27, 1995.
8. DCCT Research Group: Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes control and Complications Trial. American Journal of Cardiology 75(14): 894-903, 1995.
9. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in over-weight patients with type 2 diabetes (UKPDS 34). The Lancet 352: 854-65, 1998.
10. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 352: 837-853, 1998.
11. Vora A, Kabadi UM: The presence of central fat distribution in men with type 1 and type 2 diabetes even in absence of obesity. Annual Meeting of American Diabetes Association: Abstract 1353, June, 1998.
12. Whiteouse FW: Insulin therapy and its shortcomings - the need for new approaches. (Review). Diabetic Medicine 14 (Suppl) 2: S5-8, 1997.